Development of PBPK model of molinate and molinate sulfoxide in rats and humans. - Wikidata - awgldk - TriplyDB

Development of PBPK model of molinate and molinate sulfoxide in rats and humans.

Development of PBPK model of molinate and molinate sulfoxide in rats and humans.

http://www.wikidata.org/entity/Q33903184

about

Prediction of Pharmacokinetics and Penetration of Moxifloxacin in Human with Intra-Abdominal Infection Based on Extrapolated PBPK Model Reconstructing organophosphorus pesticide doses using the reversed dosimetry approach in a simple physiologically-based pharmacokinetic model Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results.Modeling bioavailability to organs protected by biological barriers.Development of Physiologically Based Organ Models to Evaluate the Pharmacokinetics of Drugs in the Testes and the Thyroid Gland.Diffusion-limited PBPK model for predicting pulmonary pharmacokinetics of florfenicol in pig.Prediction of the pharmacokinetics and tissue distribution of levofloxacin in humans based on an extrapolated PBPK model.Determination of tissue to blood partition coefficients for nonvolatile herbicides, insecticides, and fungicides using negligible depletion solid-phase microextraction (nd-SPME) and ultrafiltration.

P2860

Q35127513-B8E6AEFD-B223-4C38-ACB3-A45C1BF5C235 Q35837860-DC9B22DB-9A65-47B4-A1ED-D6EF18B192E2 Q38016204-E1AA0EE3-7244-44E8-9207-AE370EE25A55 Q38288015-96E84CAA-0AC5-4C89-90DE-CBDC2D388961 Q38750635-6C1F4401-CABD-42E1-A2F0-5D8B73D8434F Q38751853-D2EE8A70-0C37-41EA-AB5E-6BD623402F0A Q41262080-2071A3AB-130D-438E-813A-B9A6DE05C06B Q44733846-A52B55F4-C6D0-4998-8156-717FE7279310

P2860

Development of PBPK model of molinate and molinate sulfoxide in rats and humans.

http://www.wikidata.org/entity/Q33903184

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Development of PBPK model of molinate and molinate sulfoxide in rats and humans.

@ast

Development of PBPK model of molinate and molinate sulfoxide in rats and humans.

@en

type

label

Development of PBPK model of molinate and molinate sulfoxide in rats and humans.

@ast

Development of PBPK model of molinate and molinate sulfoxide in rats and humans.

@en

prefLabel

Development of PBPK model of molinate and molinate sulfoxide in rats and humans.

@ast

Development of PBPK model of molinate and molinate sulfoxide in rats and humans.

@en

P1433

Q33903184-069D9E6F-4193-450C-8793-F82B55B55251

P1476

Q33903184-A096A480-568D-4070-B700-47E0C910305B

P2093

Q33903184-ACDB301D-575F-4982-95BE-D85F31CB52DF

P2860

Q33903184-07AE0091-85E0-4E74-82FB-3D1E43506C5A

Q33903184-09449954-C75D-43CA-A21C-B84D79688F3F

Q33903184-0FF58301-CBC2-48F9-992F-1EBA3DE8CD9D

Q33903184-104B693E-EF55-4B29-B650-834181272D95

Q33903184-2328E2B4-16F7-4729-8641-D357EE1EEBAE

Q33903184-2BF13A40-807C-4DA6-930D-21F5949F9DCF

Q33903184-36987947-32CA-4DDE-BBCD-71E6B0D713A0

Q33903184-53EF871A-E118-46D9-BAE6-9E8D11CAE171

Q33903184-563620BF-8D2A-47A5-A9EE-75D459BE171E

Q33903184-569CECDD-34D3-4428-9E11-7B172DA82FA2

P304

Q33903184-C4783782-A2A3-45B9-B63B-A994F26D4F84

P31

Q33903184-7134A915-1BAD-4CB0-8BFF-5E4447DE1F38

P356

Q33903184-18BCBE5E-5E54-48F9-9DEE-F2881D541276

P407

Q33903184-EDFEBE4D-45FA-478F-99A8-39C1652EF92E

P433

Q33903184-D0AE9A78-669D-46CE-9D0A-B3DCDE329CC0

P478

Q33903184-9E70D188-F3D7-4D38-AA93-77AC0FA0A266

P577

Q33903184-3F1F2ACA-BC3B-440F-8DD0-4005DC3CD072

P5875

Q33903184-64FF4767-1AD1-475F-A696-D9A613286967

P698

Q33903184-D2A69C0C-B808-4E24-B5E0-25D349DFF5D7

P921

Q33903184-9760B121-8806-4FDD-A5E7-3841F1981B99

P932

Q33903184-EA819CCD-5847-4718-86FB-285385F790ED

P356

J.YRTPH.2009.01.003

P1433

Regulatory Toxicology and Pharmacology

P1476

Development of PBPK model of molinate and molinate sulfoxide in rats and humans.

@en

P2093

Andrew Campbell

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolism and covalent binding of [14C]toluene by human and rat liver microsomal fractions and liver slices

Identification of a S-hexahydro-1H-azepine-1-carbonyl adduct produced by molinate on rat hemoglobin beta(2) and beta(3) chains in vivo.

Identification of a carboxylesterase as the major protein bound by molinate.

Characterization of S-(N,N-Dialkylaminocarbonyl)cysteine Adducts and Enzyme Inhibition Produced by Thiocarbamate Herbicides in the Rat.

Heterogeneity of human adipose blood flow.

Mode of action and tissue dosimetry in current and future risk assessments.

Adrenal cholesterol uptake from plasma lipoproteins: regulation by corticotropin.

Mode of action: reduction of testosterone availability--molinate-induced inhibition of spermatogenesis.

An algorithm for predicting tissue: blood partition coefficients of organic chemicals from n-octanol: water partition coefficient data.

Thiocarbamate sulfoxides: potent, selective, and biodegradable herbicides.

P304

195-204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YRTPH.2009.01.003

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26310101

http://www.w3.org/2001/XMLSchema#string

P698

19545510

http://www.w3.org/2001/XMLSchema#string

P921

P932

2883018

http://www.w3.org/2001/XMLSchema#string